| | Cancer | Cancer Treatment
Multiple Myeloma: Treatment Landscape and Care Access
Multiple myeloma (MM) is a plasma cell malignancy. Treatment is stratified by transplant eligibility, risk stratification (R-ISS), and patient factors.
Standard Treatment Phases
- Induction: Triplet regimens preferred.
- Transplant-eligible: VRd (bortezomib/lenalidomide/dex), D-VRd (daratumumab + VRd), KRd (carfilzomib-based).
- Transplant-ineligible: DRd (daratumumab/len/dex), VRd-lite, Rd (len/dex).
- Consolidation: High-dose melphalan (HDM) + autologous stem cell transplant (ASCT) for eligible patients. Tandem transplant in select trials.
- Maintenance: Lenalidomide (standard); bortezomib/len for high-risk; daratumumab-based in trials. Continue until progression/toxicity.
- Relapse/Refractory: Sequential lines: anti-CD38 (daratumumab, isatuximab), proteasome inhibitors (carfilzomib, ixazomib), IMiDs (pomalidomide), BCL-2 inhibitor (venetoclax for t(11;14)), bispecifics (teclistamab, talquetamab), CAR-T (ide-cel, ciltacabtagene). Clinical trials prioritized.
Supportive Care
- Bone health: Zoledronic acid/denosumab.
- Infection prophylaxis: IVIG if hypogammaglobulinemia; antivirals, PJP prophylaxis.
- Renal protection, anemia management, VTE prophylaxis.
Finding Expert Care
Seek NCI-designated Comprehensive Cancer Centers or academic myeloma programs (IMWG-affiliated). Multidisciplinary team: hematologist, transplant specialist, nurse navigator, pharmacist, social worker. NCCN Guidelines and SparkCures/ClinicalTrials.gov for trial matching.
Cancer Treatment - Related Articles
- Meaningful Cancer Gifts: Unique Ideas for Support & Comfort
- Lung Cancer Treatment Options & Clinical Trials | [Your Company Name]
- Cancer & Nutrition: Understanding Dietary Impacts & Supportive Care
- Essiac: Understanding the History and Potential of this Herbal Remedy
- Neoadjuvant Chemotherapy: Definition, Purpose & Cancer Treatment
- Leading Pediatric Cancer Hospitals: Specialized Care & Treatment
- Steroid Side Effects in Cancer Treatment: What to Expect
